EXC
51
-2
PM
50
-4
CHD
34
-5
MCK
52
-3
HSIC
57
4
PVH
62
2
DGX
29
-3
PFG
33
-3
AMGN
33
-3
MTB
42
-4
LH
36
-3
AN
55
-2
AA
29
-5
AMP
54
2
TDC
86
2
MAT
43
2
FIS
50
4
HCP
52
9
MCD
57
-5
BBY
48
2
EXC
51
-2
PM
50
-4
CHD
34
-5
MCK
52
-3
HSIC
57
4
PVH
62
2
DGX
29
-3
PFG
33
-3
AMGN
33
-3
MTB
42
-4
LH
36
-3
AN
55
-2
AA
29
-5
AMP
54
2
TDC
86
2
MAT
43
2
FIS
50
4
HCP
52
9
MCD
57
-5
BBY
48
2
Financhill
Back

Replimune Group Vs. Nuvalent Industry Stock Comparison

Sell
29

REPL
Replimune Group

Last Price:
12.65
Seasonality Move:
-15.42%
Sell
29

NUVL
Nuvalent

Last Price:
93.72
Seasonality Move:
-4.29%
Sell
29
Replimune Group (REPL) is a Sell

Is Replimune Group a Buy, Sell or Hold?

  • The current Replimune Group [REPL] share price is $12.64. The Score for REPL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • REPL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
29
Nuvalent (NUVL) is a Sell

Is Nuvalent a Buy, Sell or Hold?

  • The current Nuvalent [NUVL] share price is $93.61. The Score for NUVL is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • NUVL is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

REPL Stock Price Chart

What is Replimune Group's stock price today?

  • The Replimune Group share price today is $12.64
    The current trend is moderately bearish and REPL is experiencing selling pressure, which indicates risk of future bearish movement.

NUVL Stock Price Chart

What is Nuvalent's stock price today?

  • The Nuvalent share price today is $93.61
    The current trend is moderately bearish and NUVL is experiencing selling pressure, which indicates risk of future bearish movement.

REPL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.28 Buy
Relative Strength Index (14 RSI): 50.11 Buy
Chaikin Money Flow: -412486 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (11.47 - 13.71) Buy
Bollinger Bands (100): (10.06 - 12.42) Buy

NUVL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 48.98 Sell
Chaikin Money Flow: -234315 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (90.71 - 95.77) Buy
Bollinger Bands (100): (79.91 - 100.93) Buy

REPL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 13.01 Sell
20-day SMA: 12.64 Buy
50-day SMA: 12.14 Buy
200-day SMA: 9.46 Buy
8-day EMA: 12.94 Sell
20-day EMA: 12.78 Sell
50-day EMA: 12.16 Buy
200-day EMA: 10.92 Buy

NUVL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 93.97 Sell
20-day SMA: 93.1 Buy
50-day SMA: 95.74 Sell
200-day SMA: 82.38 Buy
8-day EMA: 93.9 Sell
20-day EMA: 93.84 Sell
50-day EMA: 93.59 Buy
200-day EMA: 83.43 Buy

Replimune Group Earnings Growth & REPL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.35 per share, and an increase next year of $0.52 per share.

Nuvalent Earnings Growth & NUVL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.61 per share, and a decrease next year of $0.69 per share.

Replimune Group Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nuvalent Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):